edaravone has been researched along with Dyspnea in 1 studies
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone usage data were collected, and adverse events (AEs) were identified from a postmarketing safety database from August 8, 2017 through August 7, 2020 (cutoff date)." | 1.72 | Analysis of the US Safety Data for Edaravone (Radicava ( Apple, S; Bower, L; Brooks, BR; Genge, A; Ji, M; Kalin, A; Oskarsson, B, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genge, A | 1 |
| Brooks, BR | 1 |
| Oskarsson, B | 1 |
| Kalin, A | 1 |
| Ji, M | 1 |
| Apple, S | 1 |
| Bower, L | 1 |
1 other study available for edaravone and Dyspnea
| Article | Year |
|---|---|
Analysis of the US Safety Data for Edaravone (Radicava
Topics: Adult; Amyotrophic Lateral Sclerosis; Disease Progression; Dyspnea; Edaravone; Humans; Respiratory I | 2022 |